
CMS released the final 2027 Physician Fee Schedule on November 4, 2026. The rule is effective January 1, 2027.
The final rule (CMS-1848-F) is worse than the proposed rule on the conversion factor, better than the proposed rule on the same-day procedure penalty, and introduces a two-tier modifier structure that will permanently divide physician reimbursement by ACO participation status.
This is not a minor technical adjustment. The final rule changes the base payment rate for every Medicare physician service, creates a permanent 16-percentage-point gap between ACO and non-ACO physicians for a broad category of office visits, and reshapes how shared savings are calculated for the 476 ACOs currently participating in the Medicare Shared Savings Program.
This article covers the final numbers, what changed from the proposed rule, and what it means for independent practices, hospital-based physicians, FQHCs, and ACO participants.
1. The Conversion Factor: Deeper Cuts Than Proposed

The 2026 conversion factor for non-qualifying providers is $33.40. For 2027, it falls to $32.63.
That is a cut of $0.77, or 2.31 percent. The proposed rule had projected a cut of 1.68 percent. The final rule is 63 basis points deeper.
For qualifying APM participants (QPs), the conversion factor moves from $33.57 to $32.95, a cut of $0.62, or 1.83 percent. The proposed rule had projected a 1.19 percent cut for this group.
Both groups take a bigger hit in the final rule than in the proposed rule.
What drives the deeper cut.
Three factors combine to produce the final conversion factor.
First, the 2.5 percent payment increase enacted by Congress in Public Law 119-21 for 2026 expires at the end of this year. That boost was always temporary. When it expires, it creates a mechanical reduction before any other adjustment is applied.
Second, the statutory payment update for 2027 is +0.25 percent for non-APM participants and +0.75 percent for APM participants. These are the base updates written into MACRA. They are real increases, but they do not come close to offsetting the expiration of the 2026 boost.
Third, CMS finalized a -0.12 percent adjustment to reflect changes in work relative value units across the code set. This is a small factor, but it moves in the wrong direction.
The net result is that every Medicare physician service pays less per relative value unit starting January 1, 2027. For a physician practice billing $2 million in Medicare annually, a 2.31 percent cut is roughly $46,000 in reduced revenue. That figure assumes no change in patient volume or coding patterns.
Why this matters more than the headline percentage.
The conversion factor applies to every Medicare Part B physician service. It is the base multiplier. When it falls, the reduction is not visible in a single line item. It is spread across every code the practice bills. Many practices will not notice the full impact until they compare 2027 to 2026 on a per-unit basis.
2. The B1 and B2 Modifiers: A Permanent Split in the Physician Payment System

Starting January 1, 2027, CMS retires the G2211 add-on code and replaces it with two new modifiers.
Modifier B1 adds 16 percent to office and outpatient evaluation and management (E/M) visits for all eligible physicians. It applies to the same encounter types that G2211 had covered: visits where the physician serves as the continuous, responsible clinician for a complex patient.
Modifier B2 adds 32 percent to the same E/M codes. It is available only to physicians participating in a Medicare Shared Savings Program (MSSP) ACO at the ENHANCED track level, or in the LEAD Model. Participation in B2 is voluntary. Critically, a B2-eligible physician can bill the modifier for any patient seen, not just patients attributed to the ACO.
This structure creates a permanent two-tier reimbursement system for office visits.
The dollar difference.
Take CPT 99213 (established patient office visit, low complexity). In 2027, the base rate is approximately $73 to $78 depending on setting and geography. Apply B1: the physician collects roughly $85 to $90. Apply B2: the same visit generates roughly $96 to $103.
That difference compounds across a full year of office visits. For a primary care physician seeing 20 established patients per day, 220 days per year, billing 99213 as the representative code, the gap between B1 and B2 is approximately $12,000 to $20,000 per year in additional revenue for the ACO participant.
What B2 requires.
To qualify for B2, the physician's group must be a participating SSP ACO at the ENHANCED track level, or enrolled in the LEAD Model. BASIC track ACO participation does not qualify. The modifier is opt-in. CMS does not automatically apply it.
What this signals.
The B2/B1 split is not an accident of policy design. CMS is using payment policy to create a financial incentive for physicians to join ACOs and to remain in them. The 16-percentage-point differential is large enough to influence practice decisions.
For independent physicians not currently in an ACO, the B2 modifier represents a reimbursement gap that widens every year they remain outside the program. For health systems and large group practices, B2 eligibility becomes a recruitment and retention argument.
For the 476 ACOs currently in MSSP, B2 is a new revenue source that arrives January 1 with no additional performance requirement beyond existing ACO participation.
3. The Same-Day Procedure Rule: 44,287 Comments Changed the Final Rule

The proposed rule would have cut payment for a second service performed on the same day as a procedure to 50 percent of the standard rate. The final rule sets that reduction at 80 percent.
That difference matters significantly for surgical specialties.
CMS received 44,287 public comments on the proposed rule. The volume and content of those comments led the agency to narrow the policy substantially.
What the final rule actually does.
When a physician performs a procedure and an evaluation and management visit on the same day for the same patient, the second service is paid at 80 percent of the standard rate rather than 100 percent. The rationale is that some work overlaps when both services occur together.
The proposed rule would have applied this reduction to 0-day, 10-day, and 90-day global surgery packages. The final rule applies it only to 0-day global procedures, which are minor procedures where the global period covers only the day of the procedure itself.
The proposed rule would have applied the reduction to any physician in the same group as the proceduralist. The final rule limits it to physicians in the same specialty within the same group. A primary care physician in a large multispecialty group is not affected by a surgeon in the same group performing a procedure.
Who is still affected.
Specialties that frequently perform same-day procedures with office visits take a revenue hit, even with the softening.
CMS projects the following specialty impacts under the final rule:
Orthopedic surgery: approximately -6 percent impact on Medicare revenue. Ear, nose, and throat surgery: -5 percent. Dermatology: -4 percent. Hand surgery: -4 percent.
On the positive side, clinical social workers see approximately +11 percent and clinical psychologists approximately +9 percent due to other code revaluations in the final rule.
The same-day rule takes effect January 1, 2027, alongside the conversion factor and modifier changes.
4. ACO and MSSP: Stronger Sharing, Easier Benchmarks

The final rule makes two changes to ACO shared savings that ACO participants will view favorably.
BASIC Level E sharing rate increases from 50 to 60 percent.
MSSP ACOs move through BASIC track levels A through E before transitioning to the ENHANCED track. At Level E, the highest BASIC level, ACOs were previously eligible to retain 50 percent of savings against their benchmark. The final rule raises that rate to 60 percent.
This is a 20 percent increase in the sharing rate for ACOs at BASIC Level E. For an ACO saving $10 million against its benchmark, the difference is $1 million in additional shared savings retained by the ACO.
Prior savings adjustment scaling increases from 50 to 75 percent.
MSSP benchmarks are recalibrated each time an ACO renews. High-performing ACOs face a "ratchet effect" where savings in one period lower the benchmark for the next period, making it harder to generate savings in subsequent periods.
The prior savings adjustment factor scales how much prior performance affects the new benchmark. The final rule raises this factor from 50 to 75 percent, which allows the benchmark to track historical performance more closely rather than dragging it down as a penalty for prior success.
This change addresses a persistent criticism of MSSP design: that it punishes ACOs for being efficient. At 75 percent scaling, an ACO that saved aggressively in one period retains more competitive runway in the next.
Program performance context.
In performance year 2024, 75 percent of the 476 participating MSSP ACOs generated shared savings totaling $4.1 billion. After CMS shared savings payments to ACOs, the program generated $2.5 billion in net savings to the Medicare Trust Funds.
The program is growing. Stronger sharing rates and a less punishing benchmark ratchet are designed to sustain that growth.
Cost-sharing waivers starting April 1, 2027.
Beginning April 1, 2027, ACOs meeting certain criteria can offer beneficiary cost-sharing waivers. This gives ACO-participating physicians a tool to reduce financial barriers to care for Medicare patients, particularly for preventive services. The timing is 90 days into the 2027 benefit year.
Benchmark guardrail.
The final rule also establishes an Accountable Care Prospective Trend (ACPT) guardrail. ACO expenditure trends used in benchmarking cannot fall more than 1 percentage point below or more than 1.5 percentage points above the national growth rate. This guardrail limits extreme benchmark adjustments that could distort the program's economics in either direction.
5. FQHCs, RHCs, and Telehealth: What the Final Rule Extends and Fixes

Federally Qualified Health Centers and Rural Health Clinics received two meaningful changes in the final rule.
Telehealth extended through December 31, 2027.
FQHCs and RHCs may continue billing telehealth visits through the end of 2027. This is an 18-month extension from the previous deadline. CMS will evaluate whether to make telehealth coverage for these sites permanent in a future rulemaking cycle.
This extension matters for Oatmeal Health customers and partners who serve rural and underserved communities. Telehealth coverage at FQHCs and RHCs enables patient contact that would otherwise require a physical visit, particularly important for lung cancer screening counseling, follow-up on LDCT results, and care navigation for high-risk patients who face transportation or distance barriers.
DSMT and MNT billable as standalone at RHCs.
Diabetes Self-Management Training (DSMT) and Medical Nutrition Therapy (MNT) are now billable as standalone services at Rural Health Clinics. Previously, these services required pairing with a qualifying visit. FQHCs had already been permitted to bill these services separately. The final rule aligns RHC policy with FQHC and physician office policy.
For RHCs serving diabetic patients, this change allows dedicated DSMT and MNT appointments to be reimbursed without bundling them into a broader visit. This simplifies billing and potentially increases the number of patients who access these services.
What is not in the rule.
The final rule does not make permanent the COVID-era telehealth flexibilities that have been repeatedly extended. It does not establish a permanent telehealth benefit for FQHCs and RHCs. It does not expand the originating site rule to allow home-based telehealth as a permanent benefit for the full range of services.
Each of these would require Congressional action or a separate CMS rulemaking. The 2027 final rule extends what it has the authority to extend and defers the larger structural questions.
6. What the Final Rule Signals About the Next Decade of Medicare Physician Policy
The 2027 PFS final rule is not an isolated event. It is the latest step in a decade-long restructuring of how CMS pays physicians and how it uses payment policy to advance delivery system goals.
Three signals stand out.
Signal one: The ACO/non-ACO divide is now structural.
The B1/B2 modifier split is not a temporary incentive. It is coded into the payment system as a permanent feature. CMS has decided that physicians in advanced APM models delivering demonstrably better value should earn more for the same visit codes.
This is a policy choice with real consequences. As the B2 modifier creates a widening revenue advantage for ACO participants, independent and non-ACO physicians face compounding pressure. The gap will likely grow over time as future rulemakings add to the structure.
Signal two: Traditional MIPS is being wound down, but slower than proposed.
The proposed rule would have ended Traditional MIPS after calendar year 2028. The final rule extends that deadline to calendar year 2030, two years later than proposed.
CMS is adding three new Merit-Based Incentive Payment System Value Pathways (MVPs) for 2027: diabetes, hypertension, and hospitalist care. The agency continues to push physicians toward MVPs as a transition vehicle on the path from Traditional MIPS to full APM participation.
Traditional MIPS will end. The timeline is now 2030 rather than 2028. Practices that have not evaluated their APM eligibility have an additional two years, but the direction of policy has not changed.
Signal three: Ambulatory specialty models are expanding.
The Ambulatory Specialty Model launches January 1, 2027. This mandatory model covers high-cost, high-variation conditions: heart failure and low back pain. It applies to participating specialty practices and measures outcomes and total cost of care over an episode.
The Ambulatory Specialty Model follows the BPCI-Advanced and radiation oncology model templates. Mandatory models create population-scale data on specialty care economics. That data shapes future payment policy.
Global surgery data collection: Paused.
The final rule pauses the MACRA Section 523 global surgery data collection program, which had required a subset of practices to report on the services furnished in the global period for 10- and 90-day surgical procedures. CMS cited administrative burden and data quality concerns. The long-term goal of revising global surgery payment based on actual services rendered is deferred, not abandoned.
Deep Dive: What This Means for Specific Practice Types
Independent primary care practices (not in an ACO).
These practices face the full 2.31 percent conversion factor cut and are eligible for B1 only. They do not qualify for B2. As B2 creates a reimbursement advantage for ACO-participating competitors, independent practices will need to evaluate ACO membership more carefully.
The BASIC track entry point for MSSP is accessible to most primary care practices. ENHANCED track, which qualifies for B2, requires a track record of performance and willingness to accept downside risk. For many small practices, the path to B2 runs through several years of BASIC track participation.
ACO participants at ENHANCED track or in LEAD Model.
These practices receive B2 eligibility starting January 1, 2027. They also benefit from the BASIC Level E sharing rate increase if they were at Level E transitioning to ENHANCED, and from the prior savings adjustment scaling if they are renewing.
The B2 modifier requires opt-in and correct billing. Practices must ensure their billing staff are trained on the modifier before January 1.
Surgical specialty practices.
Orthopedic, ENT, dermatology, and hand surgery practices take a negative hit from the same-day procedure rule even in its softened form. The projected specialty impacts are real: -6 percent for ortho, -5 percent for ENT, -4 percent for derm and hand surgery.
These practices should model the specific same-day scenarios they currently bill and calculate the revenue impact of the 80 percent rate on those encounters. The 0-day global restriction limits the scope, but high-volume procedure practices will see meaningful reductions.
FQHCs and RHCs.
The telehealth extension through December 31, 2027 is the headline for this group. FQHCs and RHCs serving high-risk populations should plan for a potential telehealth cliff at the end of 2027 if Congress does not act. The last two years have seen repeated last-minute extensions. That pattern may continue, but operational plans should not depend on it.
The DSMT and MNT change benefits RHCs with active diabetes care programs. Standalone billing enables these services to be delivered without attaching them to a broader office visit, which can complicate scheduling and documentation.
Hospital-based physicians in employed settings.
These physicians are typically insulated from the direct conversion factor impact, as their compensation is set by hospital contracts rather than tied directly to Medicare collections. However, the B2 modifier may influence hospital system strategy. Systems participating in MSSP at ENHANCED track can offer B2 eligibility as a recruitment advantage for primary care physicians, which may accelerate ACO enrollment among hospital-employed physicians.
What This Means for You
The final rule affects every organization that bills Medicare Part B physician services. Here is what to do before January 1, 2027.
Review your ACO status. If your practice is eligible for MSSP but not currently enrolled, model the revenue impact of B2 eligibility against the requirements for ENHANCED track participation. The conversion factor cut is unavoidable. The B1/B2 differential is not.
Audit your same-day billing. Identify the volume of encounters where your practice bills a procedure with an E/M on the same day. For 0-day global procedures in your specialty, calculate the revenue impact of the 80 percent reduction. Build that into 2027 budget projections now.
Plan for telehealth continuity. If your FQHC or RHC relies on telehealth volume, the December 31, 2027 deadline is 14 months away. Build a contingency plan for a scenario where the extension does not renew.
Update billing protocols for B1 and B2. G2211 is retired. The new modifier structure requires updated billing procedures and staff training. January 1 is the effective date.
Track MIPS transition timeline. Traditional MIPS ends after 2030. That is two years later than proposed, but the direction has not changed. Evaluate your MVP readiness and APM eligibility now.
Lung Cancer Screening and the Payment Policy Connection
At Oatmeal Health, we focus on early detection, specifically on closing the gap between patients who need low-dose CT lung cancer screening and those who actually receive it.
The 2027 PFS final rule touches this work in two direct ways.
First, the telehealth extension through December 31, 2027 preserves remote access to shared decision-making visits, which are required before LDCT screening under Medicare. For high-risk patients in rural areas or with limited transportation, a telehealth-based shared decision-making encounter is often the difference between a screening that happens and one that does not. That encounter is billable at FQHCs and RHCs through the end of 2027. After that, the coverage framework for telehealth visits depends on Congressional action.
Second, the B2 modifier creates a financial incentive structure that rewards ACO-participating physicians for comprehensive, continuous primary care relationships. Those relationships are where lung cancer screening counseling happens. A physician with a longitudinal relationship with a high-risk smoker is better positioned to initiate and follow through on the screening conversation than one seeing the patient episodically. Payment policy that rewards longitudinal relationships rewards the conditions under which screening decisions get made.
The payment system is moving toward rewarding value-based care at scale. Lung cancer screening is preventive care at scale. The connection is not theoretical. It runs through every primary care visit where a physician decides whether to bring up risk factors, order a screening, and follow the results.
About Oatmeal Health
Oatmeal Health is a clinical intelligence company focused on closing gaps in preventive cancer screening. Our platform helps health systems, FQHCs, and physician practices identify high-risk patients, navigate screening workflows, and document outcomes. We specialize in lung cancer screening using low-dose CT, the only imaging modality with proven mortality benefit for high-risk adults.
Learn more at oatmealhealth.com.
Key References
CMS 2027 Physician Fee Schedule Final Rule (CMS-1848-F), released November 4, 2026: https://www.cms.gov/medicare/payment/fee-schedules/physician
CMS 2027 PFS Final Rule Fact Sheet: https://www.cms.gov/newsroom/fact-sheets/calendar-year-2027-medicare-physician-fee-schedule-final-rule
CMS Medicare Shared Savings Program Final Rule Fact Sheet: https://www.cms.gov/newsroom/fact-sheets/calendar-year-2027-medicare-shared-savings-program-final-rule
Federal Register CMS-1848-F: https://www.federalregister.gov/documents/2026/11/04/2026-24108/medicare-program-revisions-to-payment-policies-under-the-physician-fee-schedule
CMS Ambulatory Specialty Model: https://innovation.cms.gov/innovation-models/ambulatory-specialty-model

